单用硼替佐米或联合伊立替康对复发或耐药的结直肠癌无效。
Bortezomib alone or in combination with irinotecan was not effective in patients with relapsed or refractory CRC.
结果：硫酸铵梯度法制备的盐酸伊立替康脂质体包封率较高75。
Results: The ammonium sulfate gradient method was used to prepare CPT-11 and get higher entrapment efficiency 75.
目的观察伊立替康联合奈达铂二线治疗小细胞肺癌的疗效及毒副反应。
Objective To evaluate the efficacy and toxicity of irinotecan combined with nedaplatin in second-line therapy of small-cell lung cancer.
结论奥曲肽可以对伊立替康引起的迟发型腹泻起到一定程度的预防作用。
ConclusionsTo some extent, octreotide could prevent irinotecan induced delayed diarrhea and alleviate intestine and colon mucositis.
采用RP - HPL C法测定盐酸伊立替康及注射液的含量和有关物质。
RP HPLC method was developed to determine irinotecan hydrochloride and its injection.
目的：探讨生姜泻心汤对伊立替康(CPT - 11)所致大鼠迟发性腹泻的预防作用。
Objective: to study the preventive function of Zingiberis Recentis Decoction for Purging Stomach-Fire on delayed-onset diarrhea caused by irinotecan (CPT-11) in rats.
其中，10羟基喜树碱、拓普替康、 伊立替康以及9氨基、9硝基喜树碱、7乙基10 羟基喜树碱等在临床显示了广泛的抗癌活性。
Among them, 10 hydroxycamptoyhecin, topotecan, camptothecin 11, 9 amino campothecin, 9 nitro campothecin and 7 ethyl 10 hydroxycamptoyhecin showed a great antitumor activity in wide verities of range.
其中，10羟基喜树碱、拓普替康、 伊立替康以及9氨基、9硝基喜树碱、7乙基10 羟基喜树碱等在临床显示了广泛的抗癌活性。
Among them, 10 hydroxycamptoyhecin, topotecan, camptothecin 11, 9 amino campothecin, 9 nitro campothecin and 7 ethyl 10 hydroxycamptoyhecin showed a great antitumor activity in wide verities of range.
应用推荐